Loading company financials…
NYSE · Services-General Medical & Surgical Hospitals, NEC · CIK 0000070318
$265.05
-0.66% · delayed 15 min
$25.21B market value
What this company does
TENET HEALTHCARE provides healthcare and runs medical facilities. It took in $21.31B last year, which makes it a large company. Of every dollar it sells, about 11 cents is left as profit.
Financial health
Generally healthy, with a few things to watch.
From TENET HEALTHCARE CORP's FY2025 annual filing · share price scored separately
Every check behind the three models, and what each one tests
Measured against FY2024, from the 10-K
Deteriorated: -41.8%
$4.06B to $2.37B
Deteriorated: −8.6 pts
19.7% to 11.1%
Improved: +126.7%
$1.12B to
It makes a profit rather than burning through money.
$2.37B earned last year
Day-to-day operations generate real cash, not just accounting profit.
$3.54B cash from operations
It keeps less of each sale as profit than it did a year ago.
19.7% → 11.1%
Filter by minute, hour, day or week
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to shrink by about 5% a year for the next 10 years. Over the last 10 years it grew by about 30% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 11 cents of every dollar of sales as profit, earning $2.37B last year.
What it earns, what it keeps, and what it costs to run — all from the same filing
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it earned $2.37B and generated $3.54B of cash from operations.
Reported annual figures
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Nothing recent
No insider trades, pending-sale notices or 5% stake filings from THC in the last few months. That is the ordinary case, not a gap.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Go deeper
Every figure above traces back to one of these filings.
Straight from SEC EDGAR — the original source for every figure above
| Filing | Filed | Covers to |
|---|---|---|
| Quarterly report(10-Q) | 2026-07-29 | 2026-06-30 |
| Major event announcement(8-K) | 2026-07-23 | 2026-07-23 |
Financial figures are from THC's 10-K for fiscal year 2025 (period ending 2025-12-31), reported under the US GAAP taxonomy. View the source filing.
5 of 7 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 2 could not be evaluated and are excluded from the total rather than counted as failures.
2.24
In the grey zone
For this model, above 2.6 is safe and below 1.1 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: -4.9%
100.0M to 95.1M
Changed: +8.5%
$931.0M to $1.01B
2 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Nothing here reads the management commentary, which is where a company explains its own numbers.
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between -7% and -4%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 2.7% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
Slowly. Sales grew 3.1% last year.
Manageable. For every $1 it owes, it owns $1.43 in assets.
On the cheaper side. Investors pay $10.7 for every $1 of yearly profit.
This company has not reported enough of the required figures to calculate this score.
At a glance
| Major event announcement(8-K) | 2026-05-29 | 2026-05-27 |
| Quarterly report(10-Q) | 2026-04-30 | 2026-03-31 |
| Major event announcement(8-K) | 2026-04-30 | 2026-04-30 |
| Shareholder voting information(DEF 14A) | 2026-04-16 | 2026-05-27 |
| Major event announcement(8-K) | 2026-04-10 | 2026-04-09 |
| Major event announcement(8-K) | 2026-03-30 | 2026-03-25 |
| Annual report(10-K) | 2026-02-17 | 2025-12-31 |
| Major event announcement(8-K) | 2026-02-11 | 2026-02-11 |
| Major event announcement(8-K) | 2026-02-02 | 2026-01-27 |
| Major event announcement(8-K) | 2025-11-24 | 2025-11-21 |
| Major event announcement(8-K) | 2025-11-18 | 2025-11-18 |
| Major event announcement(8-K) | 2025-11-05 | 2025-11-04 |
| Major event announcement(8-K) | 2025-11-03 | 2025-11-03 |
| Quarterly report(10-Q) | 2025-10-28 | 2025-09-30 |
| Major event announcement(8-K) | 2025-10-28 | 2025-10-28 |
| Quarterly report(10-Q) | 2025-07-30 | 2025-06-30 |
| Major event announcement(8-K) | 2025-07-22 | 2025-07-22 |
| Major event announcement(8-K) | 2025-06-05 | 2025-05-30 |
Coverage from the last 30 days
Tenet Healthcare (THC), What Is Behind The Fresh Attention?
Yahoo Finance ·
Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain
Yahoo Finance ·
Tenet Publishes Q2-2026 Financial Results Q&A Transcript
Yahoo Finance ·
Tenet Healthcare and Archrock have been highlighted as Zacks Bull and Bear of the Day
Yahoo Finance ·
Tenet to Participate in the Wells Fargo Healthcare Conference
Yahoo Finance ·
Bull of the Day: Tenet Healthcare (THC)
Yahoo Finance ·
Should Value Investors Buy Tenet Healthcare (THC) Stock?
Yahoo Finance ·
ThreeD Capital Inc. Congratulates Tenet Fintech Group Inc. On Its Second Quarter 2026 Financial Results
Yahoo Finance ·
Tenet Reports Revenue of CAD $52.8M and a Net Profit of CAD $2.7M for the Second Quarter of 2026
Yahoo Finance ·
Tenet (THC) is an Incredible Growth Stock: 3 Reasons Why
Yahoo Finance ·
Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?
Yahoo Finance ·
Tenet Healthcare (THC) Stock May Be 49% Undervalued After Raised Outlook
Yahoo Finance ·
Primary sources and further research